Xiaorui Yao Selected Research

Biomarkers (Surrogate Marker)

1/2024	Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.
2/2018	Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaorui Yao Research Topics

Disease

6	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2016
2	Insulin Resistance 12/2020 - 01/2012
2	Body Weight (Weight, Body) 01/2018 - 01/2012
2	Obesity 01/2013 - 01/2012
1	Inflammation (Inflammations) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 03/2014
1	Pancreatitis 03/2014
1	Disease Progression 03/2014
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2013
1	Metabolic Diseases (Metabolic Disease) 01/2013
1	Hypercholesterolemia 08/2004
1	Coronary Disease (Coronary Heart Disease) 02/2004

Drug/Important Bio-Agent (IBA)

4	TabletsIBA 01/2024 - 01/2018
4	hugan qingzhiIBA 01/2024 - 01/2018
4	LipidsIBA 12/2020 - 01/2013
4	CholesterolIBA 01/2018 - 02/2004
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2018
2	CytokinesIBA 01/2024 - 02/2018
2	AntioxidantsIBA 12/2020 - 02/2018
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 01/2012
2	Acetates (Acetic Acid Esters)FDA Link 01/2016 - 01/2012
2	Hormones (Hormone)IBA 01/2013 - 01/2012
1	CalciumIBA 12/2020
1	CationsIBA 02/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2018
1	LDL CholesterolIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	ProteomeIBA 12/2017
1	AdiponectinIBA 01/2016
1	alisol AIBA 01/2016
1	alisol A 24-acetateIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Sterol Regulatory Element Binding Protein 1IBA 01/2016
1	IncretinsIBA 03/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2014
1	SterolsIBA 01/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2013
1	DiglyceridesIBA 01/2013
1	stigmastanolIBA 01/2013
1	gamma-sitosterol (beta-sitosterol)IBA 01/2013
1	Peptide YYIBA 01/2013
1	StigmasterolIBA 01/2013
1	PropionatesIBA 01/2012
1	Butyrates (Butyrate)IBA 01/2012
1	Lipoproteins (Lipoprotein)IBA 08/2004
1	Ezetimibe (Zetia)FDA Link 08/2004
1	Dietary CholesterolIBA 02/2004

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2018
1	Therapeutics 03/2014